Sagittarius Life Science (3205) — Capital Reinvestment Ratio
Latest as of September 2025:
0.66x
Sagittarius Life Science (3205) has a Capital Reinvestment Ratio of 0.66x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$125.00K) in capital expenditures (NT$83.00K). See cash generation quality of Sagittarius Life Science to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.66x
Capex / Operating Cash Flow
Operating Cash Flow
NT$125.00K
TWD
Capital Expenditures
NT$83.00K
TWD
Data as of
Sep 2025
Most recent filing
Sagittarius Life Science Capital Reinvestment Ratio (2015–2016)
This chart tracks Sagittarius Life Science's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Sagittarius Life Science (2015–2016)
Year-by-year Capital Reinvestment Ratio for Sagittarius Life Science from 2015 to 2016. For live market cap and broader valuation context, see Sagittarius Life Science (3205) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.05x | NT$360.37 Million | NT$19.76 Million | ▲ +342.3% |
| 2015 | 0.01x | NT$237.94 Million | NT$2.95 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow